Inovalon Holdings, Inc. (NASDAQ:INOV) President Robert A. Wychulis sold 85,828 shares of the stock in a transaction on Tuesday, December 5th. The shares were sold at an average price of $15.54, for a total transaction of $1,333,767.12. Following the sale, the president now directly owns 466,286 shares of the company’s stock, valued at approximately $7,246,084.44. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website.
Shares of Inovalon Holdings, Inc. (NASDAQ INOV) traded down $0.05 during midday trading on Friday, reaching $15.30. 360,380 shares of the company’s stock traded hands, compared to its average volume of 565,830. The company has a quick ratio of 5.62, a current ratio of 5.62 and a debt-to-equity ratio of 0.31. Inovalon Holdings, Inc. has a 1-year low of $8.60 and a 1-year high of $17.80. The company has a market cap of $2,240.00 and a price-to-earnings ratio of 73.33.
Inovalon (NASDAQ:INOV) last issued its quarterly earnings data on Wednesday, November 1st. The technology company reported $0.09 EPS for the quarter, topping the Thomson Reuters’ consensus estimate of $0.08 by $0.01. Inovalon had a net margin of 4.07% and a return on equity of 4.63%. The business had revenue of $115.90 million during the quarter, compared to analyst estimates of $114.79 million. During the same period in the prior year, the business earned $0.10 EPS. The company’s revenue for the quarter was up 10.4% on a year-over-year basis. research analysts expect that Inovalon Holdings, Inc. will post 0.24 EPS for the current year.
Several equities research analysts have weighed in on INOV shares. Morgan Stanley raised shares of Inovalon from an “underweight” rating to an “equal weight” rating and increased their price target for the company from $9.00 to $14.00 in a research report on Tuesday, September 12th. TheStreet raised shares of Inovalon from a “d+” rating to a “c-” rating in a research report on Thursday, October 5th. Zacks Investment Research cut shares of Inovalon from a “hold” rating to a “sell” rating in a research report on Tuesday, November 7th. ValuEngine raised shares of Inovalon from a “sell” rating to a “hold” rating in a research report on Wednesday, September 6th. Finally, KeyCorp reissued a “hold” rating on shares of Inovalon in a research report on Tuesday, September 12th. Three investment analysts have rated the stock with a sell rating and six have issued a hold rating to the company. Inovalon has a consensus rating of “Hold” and a consensus target price of $12.00.
TRADEMARK VIOLATION WARNING: This story was published by StockNewsTimes and is owned by of StockNewsTimes. If you are reading this story on another domain, it was illegally copied and republished in violation of United States & international trademark and copyright legislation. The correct version of this story can be accessed at https://stocknewstimes.com/2017/12/08/robert-a-wychulis-sells-85828-shares-of-inovalon-holdings-inc-inov-stock.html.
Inovalon Holdings, Inc (Inovalon) is a technology company. The Company provides cloud-based platforms empowering a data-driven transformation from volume-based to value-based models to the healthcare industry. Leveraging large-scale data interconnectivity capabilities, unparalleled proprietary data sets, advanced analytics, data-driven intervention systems, and subject matter expertise, Inovalon enables the assessment and improvement of clinical and quality outcomes and financial performance across the healthcare ecosystem.
Receive News & Ratings for Inovalon Holdings Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Inovalon Holdings Inc. and related companies with MarketBeat.com's FREE daily email newsletter.